Copeptin and its potential role in diagnosis and prognosis of various diseases
Open Access
- 1 January 2013
- journal article
- review article
- Published by Croatian Society for Medical Biochemistry and Laboratory Medicine in Biochemia Medica
- Vol. 23 (2), 172-192
- https://doi.org/10.11613/bm.2013.021
Abstract
The need for faster diagnosis, more accurate prognostic assessment and treatment decisions in vari-ous diseases has lead to the investigations of new biomarkers. The hope is that this new biomarkers will enable early decision making in clinical practice. Arginine vasopressin (AVP) is one of the main hormones of the hypothalamic-pituitary-adrenal axis. Its main stimulus for secretion is hyperosmolarity, but AVP system is also stimulated by exposure of the body to endogenous stress. Reliable measurement of AVP concentration is difficult because it is subject to preanalytical and analytical errors. It is therefore not used in clinical practice. Copeptin, a 39-aminoacid glycopeptide, is a C-terminal part of the precursor pre-provasopressin (pre-proAVP). Activation of AVP system stimu-lates copeptin secretion into the circulation from the posterior pituitary gland in equimolar amounts with AVP. Therefore, copeptin directly reflects AVP concentration and can be used as surrogate bio-marker of AVP secretion. Even mild to moderate stress situations contribute to release of copeptin. These reasons have lead to a handful of research on copeptin in various diseases. This review sum-marizes the current achievements in the research of copeptin as a diagnostic and prognostic marker and also discusses its association in different disease processes.Keywords
This publication has 53 references indexed in Scilit:
- Hyponatraemia in imported malaria: the pathophysiological role of vasopressinMalaria Journal, 2012
- Correlation of Plasma Copeptin and Vasopressin Concentrations in Hypo-, Iso-, and Hyperosmolar StatesJournal of Clinical Endocrinology & Metabolism, 2011
- Copeptin: clinical use of a new biomarkerTrends in Endocrinology & Metabolism, 2008
- Copeptin: a new and promising diagnostic and prognostic markerCritical Care, 2008
- Changes in Plasma Copeptin, the C-Terminal Portion of Arginine Vasopressin during Water Deprivation and Excess in Healthy SubjectsJournal of Clinical Endocrinology & Metabolism, 2007
- Anterior and Posterior Pituitary Function Testing with Simultaneous Insulin Tolerance Test and a Novel Copeptin AssayJournal of Clinical Endocrinology & Metabolism, 2007
- C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial InfarctionCirculation, 2007
- Copeptin and Arginine Vasopressin Concentrations in Critically Ill PatientsJournal of Clinical Endocrinology & Metabolism, 2006
- Course of Vasopressin and Copeptin Plasma Concentrations in a Patient with Severe Septic ShockAnaesthesia and Intensive Care, 2006
- Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patientsPeptides, 2005